PROFOUND MEDICAL CORP. (PROF) ROA
- 2026-06-30: ROA -52.49%.
- 2026-03-31: ROA -52.96%.
- 2025-12-31: ROA -54.95%.
- 2025-09-30: ROA -93.00%.
Complete source-backed roa history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|---|
| 2026-06-30 | -52.49% |
| 2026-03-31 | -52.96% |
| 2025-12-31 | -54.95% |
| 2025-09-30 | -93.00% |
| 2025-06-30 | -82.01% |
| 2025-03-31 | -52.50% |
| 2024-12-31 | -39.60% |
Annual ROA
| Date | ROA |
|---|---|
| 2025-12-31 | -54.95% |
| 2024-12-31 | -39.60% |
| 2023-12-31 | -64.43% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |